COL4A5 Gene Alport Syndrome X-Linked Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for COL4A5 Gene Alport Syndrome, X-Linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL4A5 Gene Alport Syndrome, X-Linked NGS Genetic DNA Test gene COL4A5.
Test Details
The COL4A5 gene is responsible for producing a protein called collagen type IV alpha-5 chain. Mutations in this gene can lead to a condition called Alport syndrome, which is an inherited disorder affecting the kidneys, ears, and eyes.
X-Linked NGS Genetic Test refers to a genetic test that uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the COL4A5 gene specifically on the X chromosome. Since Alport syndrome is an X-linked disorder, meaning it is more commonly seen in males, this test can help identify mutations in the COL4A5 gene that may be responsible for the syndrome.
The X-Linked NGS Genetic Test involves collecting a sample of DNA, typically through a blood sample, from the individual suspected of having Alport syndrome. The DNA is then sequenced using NGS technology to identify any variations or mutations in the COL4A5 gene.
The results of the test can help confirm a diagnosis of Alport syndrome and provide information about the specific genetic mutation involved. This genetic test can be helpful in identifying individuals at risk of developing Alport syndrome, especially in cases where there is a family history of the condition. It can also aid in genetic counseling and family planning decisions.
Additionally, the test can assist in the early detection and management of Alport syndrome, allowing for timely intervention and treatment to slow down the progression of the disease.
Test Name | COL4A5 Gene Alport syndrome X-Linked Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for COL4A5 Gene Alport syndrome, X-Linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL4A5 Gene Alport syndrome, X-Linked NGS Genetic DNA Test gene COL4A5 |
Test Details |
The COL4A5 gene is responsible for producing a protein called collagen type IV alpha-5 chain. Mutations in this gene can lead to a condition called Alport syndrome, which is an inherited disorder affecting the kidneys, ears, and eyes. X-Linked NGS Genetic Test refers to a genetic test that uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the COL4A5 gene specifically on the X chromosome. Since Alport syndrome is an X-linked disorder, meaning it is more commonly seen in males, this test can help identify mutations in the COL4A5 gene that may be responsible for the syndrome. The X-Linked NGS Genetic Test involves collecting a sample of DNA, typically through a blood sample, from the individual suspected of having Alport syndrome. The DNA is then sequenced using NGS technology to identify any variations or mutations in the COL4A5 gene. The results of the test can help confirm a diagnosis of Alport syndrome and provide information about the specific genetic mutation involved. This genetic test can be helpful in identifying individuals at risk of developing Alport syndrome, especially in cases where there is a family history of the condition. It can also aid in genetic counseling and family planning decisions. Additionally, the test can assist in the early detection and management of Alport syndrome, allowing for timely intervention and treatment to slow down the progression of the disease. |